Aldeyra Therapeutics, Inc. (ALDX)
0.7908
0.00 (0.00%)
USD |
NASDAQ |
Oct 15, 10:53
Aldeyra Therapeutics Total Long Term Debt (Quarterly) : 0.00 for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 15.30M |
| December 31, 2025 | 15.25M |
| September 30, 2025 | 15.27M |
| June 30, 2025 | 15.29M |
| March 31, 2025 | 15.31M |
| December 31, 2024 | 15.03M |
| September 30, 2024 | 15.35M |
| June 30, 2024 | 15.38M |
| March 31, 2024 | 15.41M |
| December 31, 2023 | 15.42M |
| September 30, 2023 | 16.12M |
| June 30, 2023 | 16.02M |
| March 31, 2023 | 15.92M |
| December 31, 2022 | 15.83M |
| September 30, 2022 | 15.75M |
| June 30, 2022 | 15.67M |
| March 31, 2022 | 15.65M |
| December 31, 2021 | 15.63M |
| September 30, 2021 | 15.61M |
| June 30, 2021 | 15.34M |
| March 31, 2021 | 15.24M |
| December 31, 2020 | 15.09M |
| September 30, 2020 | 14.95M |
| June 30, 2020 | 13.92M |
| Date | Value |
|---|---|
| March 31, 2020 | 14.67M |
| December 31, 2019 | 14.53M |
| September 30, 2019 | 14.45M |
| June 30, 2019 | 0.1161M |
| March 31, 2019 | 0.1568M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 1.348M |
| June 30, 2018 | 1.344M |
| March 31, 2018 | 1.340M |
| December 31, 2017 | 1.336M |
| September 30, 2017 | 1.332M |
| June 30, 2017 | 1.327M |
| March 31, 2017 | 1.321M |
| December 31, 2016 | 1.316M |
| September 30, 2016 | 1.310M |
| June 30, 2016 | 1.303M |
| March 31, 2016 | 1.296M |
| December 31, 2015 | 1.289M |
| September 30, 2015 | 1.281M |
| June 30, 2015 | 1.272M |
| March 31, 2015 | 1.262M |
| December 31, 2014 | 1.253M |
| September 30, 2014 | 1.241M |
| June 30, 2014 | 1.223M |
| March 31, 2014 | 1.205M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.371B |
| Oncolytics Biotech, Inc. | 0.31M |
| Sangamo Therapeutics, Inc. | 19.33M |
| Sarepta Therapeutics, Inc. | 1.046B |
| Anixa Biosciences, Inc. | 0.128M |